References
- 1. Rammaert B, Lanternier F, Poirée S, Kania R, Lortholary O. Diabetes and mucormycosis: A complex interplay. Diabetes Metab. 2012;38(3):193-204. DOI: 10.1016/j.diabet.2012.01.002.10.1016/j.diabet.2012.01.002
- 2. deShazo RD, O’Brien M, Chapin K, Soto-Aguilar M, Gardner L, Swain R. A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg. 1997;123(11):1181-8. DOI: 10.1001/archotol.1997.01900110031005.10.1001/archotol.1997.01900110031005
- 3. Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am. 2000;33(2):349-65. DOI: 10.1016/s0030-6665(00)80010-9.10.1016/S0030-6665(00)80010-9
- 4. Blitzer A, Lawson W, MEYERS BR, Biller HF. Patent survival factor in paransal sinus mucomycosis. Laryngoscope. 1980;90(4):635-48. DOI: 10.1288/00005537-198004000-00010.10.1288/00005537-198004000-00010
- 5. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54 Suppl 1:S23-34. DOI: 10.1093/cid/cir866.10.1093/cid/cir866
- 6. Sohail MA, Al Khabori M, Hyder J, Verma A. Acute fulminant fungal sinusitis: clinical presentation, radiological findings and treatment. Acta Trop. 2001;80(2):177-85. DOI: 10.1016/s0001-706x(01)00174-7.10.1016/S0001-706X(01)00174-7
- 7. Meas T, Mouly S, Kania R, Hervé D, Herman P, Kévorkian JP, et al. Zygomycosis: an uncommon cause for peripheral facial palsy in diabetes. Diabetes Metab. 2007;33(3):227-9. DOI: 10.1016/j.diabet.2006.12.001. Epub 2007 Mar 27.10.1016/j.diabet.2006.12.00117392007
- 8. Badea C, Sarafoleanu C, Marza A. Rhinosinusal mucormycosis: Literature review and some particular cases. Romanian Journal of Rhinology. 2019;9(35):129-37. DOI: 10.2478/rjr-2019-0015.10.2478/rjr-2019-0015
- 9. Hosseini SMS, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol. 2005;262(11):932-8. DOI: 10.1007/s00405-005-0919-0. Epub 2005 May 13.10.1007/s00405-005-0919-015891927
- 10. Wiatrak BJ, Willging P, Myer CM 3rd, Cotton RT. Functional endoscopic sinus surgery in the immunocompromised child. Otolaryngol Head Neck Surg. 1991;105(6):818-25. DOI: 10.1177/019459989110500608.10.1177/0194599891105006081787972
- 11. Walsh TJ, Skiada A, Cornely OA, Roilides E, Ibrahim A, Zaoutis T, et al. Development of new strategies for early diagnosis of mucormycosis from bench to bedside. Mycoses. 2014;57(s3):2-7. DOI: 10.1111/myc.12249.10.1111/myc.12249
- 12. Mallis A, Mastronikolis SN, Naxakis SS, Papadas AT. Rhinocerebral mucormycosis: an update. Eur Rev Med Pharmacol Sci. 2010;14(11):987-92.
- 13. Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D’Souza O. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003;51(3):231-6.
- 14. Ramírez C, Hernández AF, Méndez V, Trejo S, Contreras R, Espinosa Monteros AL, et al. Mucormicosis en un paciente con agranulocitosis secundaria a metimazol. Informe de un caso. Gac Med Mex. 2009;145(3):235-8.
- 15. García Insausti C, Majado Martínez MJ, García Hernández AM, Moraleda Jiménez JM. Protocolo diagnóstico de la neutropenia. Med. 2012;11(21):1309-12. DOI: 10.1016/S0304-5412(12)70454-7.10.1016/S0304-5412(12)70454-7
- 16. Frey Gutierrez ME, Martínez GW, Alvarez Milán D, Acuña Vassallo JP, Trinajstic EM. Mucormicosis cutanea-presentación de caso clínico, recuerdo de etiopatogenia diagnóstico y tratamiento. Rev la Fac Ciencias Médicas. 2016;73(4):302-5. DOI: 10.31053/1853.0605. v73.n4.15687.
- 17. Ali A, Abbasi AS, Amjad T, Saleem F. Erythrocyte Sedimentation Rate and C-Reactive Protein as marker of acute versus chronic medical conditions. J Ayub Med Coll Abbottabad. 2019;31(1):39-45.
- 18. Wu D, Zhang LM, Jiang Y. Clinical features of mucormycosis. Acta Acad Med Sin. 2010;32(4):461-4.
- 19. Méndez-Tovar LJ, Mejía-Mercado JA, Manzano-Gayosso P, Hernández-Hernández F, López-Martínez R, Silva GI. Frecuencia de micosis invasivas en un hospital mexicano de alta especialidad. Experiencia de 21 años. Rev Med Inst Mex Seguro Soc. 2016;54(5):581-7.
- 20. Park G, Song SY, Ahn JH, Kim WL, Lee JS, Jeong SY, et al. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma. Radiat Oncol. 2019;14(1):116. DOI: 10.1186/s13014-019-1331-z.10.1186/s13014-019-1331-z661089231272506
- 21. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis. 1998;27(5):1138-47.10.1093/clinids/27.5.1138
- 22. Jiang N, Zhao G, Yang S, Lin J, Hu L, Che C, et al. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially. BMC Ophthalmol. 2016;16:10. DOI: 10.1186/s12886-016-0189-1.10.1186/s12886-016-0189-1470999726758904
- 23. Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26-34. DOI: 10.1016/j.cmi.2018.07.011.10.1016/j.cmi.2018.07.01130036666
- 24. Jayalakshmi SS, Reddy RG, Borgohain R, Subramanyam C, Panigrahi M, Sundaram C, et al. Predictors of mortality in rhinocerebral mycosis. Neurol India. 2007;55(3):292-7. DOI: 10.4103/0028-3886.35692.10.4103/0028-3886.3569217921660
- 25. Corzo-León DE, Chora-Hernández LD, Rodríguez-Zulueta AP, Walsh TJ. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases. Med Mycol. 2018;56(1):29-43. DOI: 10.1093/mmy/myx017.10.1093/mmy/myx01728431008
- 26. Abdollahi A, Shokohi T, Amirrajab N, Poormosa R, Kasiri A, Motahari SJ, et al. Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis: A retrospective analysis. Curr Med Mycol. 2016;2(4):15-23. DOI: 10.18869/acadpub.cmm.2.4.15.10.18869/acadpub.cmm.2.4.15561169228959791
- 27. Talmi YP, Goldschmied-Reouven A, Bakon M, Barshack I, Wolf M, Horowitz Z, et al. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg. 2002;127(1):22-31. DOI: 10.1067/mhn.2002.126587.10.1067/mhn.2002.12658712161726
- 28. Wali U, Balkhair A, Al-Mujaini A. Cerebro-rhino orbital mucormycosis: An update. J Infect Public Health. 2012;5(2):116-26. DOI: 10.1016/j.jiph.2012.01.003.10.1016/j.jiph.2012.01.003
- 29. Cho HJ, Jang MS, Hong SD, Chung SK, Kim HY, Dhong HJ. Prognostic factors for survival in patients with acute invasive fungal rhinosinusitis. Am J Rhinol Allergy. 2015;29(1):48-53. DOI: 10.2500/ajra.2015.29.4115.10.2500/ajra.2015.29.4115
- 30. Millon L, Herbrecht R, Grenouillet F, Morio F, Alanio A, Letscher-Bru V, et al. Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF). Clin Microbiol Infect. 2016;22(9):810. e1-810.e8. DOI: 10.1016/j.cmi.2015.12.006.10.1016/j.cmi.2015.12.006
- 31. Sun HY, Singh N. Mucormycosis: its contemporary face and management strategies. Lancet Infect Dis. 2011;11(4):301-11. DOI: 10.1016/S1473-3099(10)70316-9.10.1016/S1473-3099(10)70316-9
- 32. McCarthy M, Rosengart A, Schuetz AN, Kontoyiannis DP, Walsh TJ. Mold infections of the central nervous system. N Engl J Med. 2014;371(2):150-160. DOI: 10.1056/NEJMra1216008.10.1056/NEJMra1216008484046125006721
- 33. Jung SH, Kim SW, Park CS, Song CE, Cho JH, Lee JH, et al. Rhino-cerebral Mucormycosis: consideration of prognostic factors and treatment modality. Auris Nasus Larynx. 2009;36(3):274-9. DOI: 10.1016/j.anl.2008.07.003. Epub 2008 Sep 10.10.1016/j.anl.2008.07.00318786790
- 34. Chan LL, Singh S, Jones D, Diaz EM, Ginsberg LE. Imaging of mucormycosis skull base osteomyelitis. AJNR Am J Neuroradiol. 2000;21(5):828-31.
- 35. Gamba JL, Woodruff WW, Djang WT, Yeates AE. Cranofacial mucormycosis: assessment with CT. Radiology. 1986;160(1):207-12. DOI: 10.1148/radiology.160.1.3715034.10.1148/radiology.160.1.37150343715034
- 36. Hargrove RN, Wesley RE, Klippenstein KA, Fleming JC, Haik BG. Indications for orbital exenteration in mucormycosis. Ophthalmic Plast Reconstr Surg. 2006;22(4):286-91. DOI: 10.1097/01. iop.0000225418.50441.ee.10.1097/01
- 37. Kashkouli MB, Abdolalizadeh P, Oghazian M, Hadi Y, Karimi N, Ghazizadeh M. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis. Br J Ophthalmol. 2019;103(10):1460-5. DOI: 10.1136/bjophthalmol-2018-312688.10.1136/bjophthalmol-2018-31268830514712